Alsheikh, Abdulrahman
Alshehri, Ali
Alzahrani, Saad
Jammah, Anwar A.
Alqahtani, Fahad
Alotaibi, Metib
Aldahash, Raed
Alhozali, Amani M.
Alsabaan, Fahad
Almehthel, Mohammed
Aljuhani, Naser
Aldabeis, Ali
Alamri, Moneer
Maghawry, Waleed
Alzaman, Naweed
Alshaikh, Alshaima
M. Alnozha, Omar
Issak, Emad R. http://orcid.org/0000-0003-4150-649X
Alsifri, Saud
Article History
Received: 18 October 2023
Accepted: 23 November 2023
First Online: 19 December 2023
Declarations
:
: Abdulrahman Alsheikh, Ali Alshehri, Saad Alzahrani, Anwar A Jammah, Fahad Alqahtani, Meteb Alotaibi, Raed Aldahash, Amani M Alhozali, Fahad Alsabaan, Mohammed Almehthel, Naser Aljuhani, Ali Aldabeis, Moneer Alamri, Waleed Maghawry, Naweed Alzaman, Alshaima Alshaikh, Omar M Alnozha, Emad R Issak and Saud Alsifri have nothing to disclose.
: The study conformed to the principles of the 2011 Declaration of Helsinki and the Good Pharmacoepidemiology Practices (GPP) guidelines. An accredited centralized institutional review board (IRB) approved the study, and informed consent was waived by the IRB as the study was retrospective. The central IRB approval covered the necessary ethics approval for all study sites. Informed consent was not required as the study is retrospective chart review study and all data is HIPAA de-identified.